t
Oxford Nanopore Technologies plc announced its participation in three investor conferences in December. The company will attend the Citi 2025 Global Healthcare Conference on December 2, the 37th Annual Piper Sandler Healthcare Conference on December 3, and the Berenberg European Conference on December 4. Fireside chats are scheduled for 9:45am EST (2:45pm GMT), 12:30pm EST (5:30pm GMT), and 3:30pm GMT, respectively, with live webcasts available for the first two events.
Oxford Nanopore Technologies plc
("Oxford Nanopore" or the "Company")
Oxford Nanopore to participate in upcoming investor conferences
27 November 2025
Oxford Nanopore Technologies plc (LSE: ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in December.
· Citi 2025 Global Healthcare Conference, Miami
Format: Analyst led fireside chat and one-on-one and group investor meetings
Date: Tuesday, 2 December
Fireside chat time: 9:45am EST (2:45pm GMT)
Webcast: click here to register
· 37th Annual Piper Sandler Healthcare Conference, New York
Format: Analyst led fireside chat and one-on-one and group investor meetings
Date: Wednesday, 3 December
Fireside chat time: 12:30pm EST (5:30pm GMT)
Webcast: click here to register
· Berenberg European Conference, Windsor
Format: Analyst led fireside chat and one-on-one and group investor meetings
Date: Thursday, 4 December
Fireside chat time: 3:30pm GMT
Live webcasts of the Citi and Piper Sandler fireside chats can be accessed at the Company's investor relations page at: https://nanoporetech.com/about/investors/reports. Webcast replays will be available for at least 30 days following the events via the same link.
-ENDS-
For further information, please contact:
Oxford Nanopore Technologies plc
Investors: [email protected]
Media: [email protected]
Teneo (communications adviser to the Company)
Tom Murray, Lisa Jarrett-Kerr
+44 (0) 20 7353 4200
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.
For more information please visit: www.nanoporetech.com